Author

Matthias M. Dollinger

Observed names: M Dollinger, M M Dollinger, M. Dollinger, M. M. Dollinger, M.M. Dollinger, Matthias Dollinger, Matthias M Dollinger

Observed institutions: National Institutes of Health, Universität Ulm, Heidelberg University, Casa Sollievo della Sofferenza, Edinburgh Royal Infirmary, Westpfalz Klinikum, University Hospital in Halle, University of Regensburg, University of Duisburg-Essen, Technical University of Munich, Martin Luther University Halle-Wittenberg, University of Tübingen, University of Edinburgh

ORCID: 0000-0003-1933-5743

Observed ORCID: 0000-0003-1933-5743

OpenAlex ID: A5101718009

Gemcitabine and oxaliplatin with or without cetuximab in advanced biliary-tract cancer (BINGO): a randomised, open-label, non-comparative phase 2 trial

2014 · David Malka, Pascale Cervera, et al. · The Lancet Oncology · 408

Hepatocyte differentiation of mesenchymal stem cells from human adipose tissue in vitro promotes hepatic integration in vivo

2008 · H Aurich, M Sgodda, et al. · Gut · 352

Functional integration of hepatocytes derived from human mesenchymal stem cells into mouse livers

2006 · Ines Aurich, Lutz P Mueller, et al. · Gut · 314

Hepatocyte differentiation of mesenchymal stem cells from rat peritoneal adipose tissue in vitro and in vivo

2007 · Malte Sgodda, Hendryk Aurich, et al. · Experimental Cell Research · 184

Update der S 3-Leitlinie Prophylaxe, Diagnostik und Therapie der Hepatitis-C-Virus(HCV)-Infektion, AWMF-Register-Nr.: 021 / 012

2010 · C. Sarrazin, T. Berg, et al. · Zeitschrift für Gastroenterologie · 166

PDF

Diagnostik und Therapie des hepatozellulären Karzinoms

2013 · T. Greten, N. Malek, et al. · Zeitschrift für Gastroenterologie · 101

PDF

Results of the CAPSID randomized trial for high-dose convalescent plasma in patients with severe COVID-19

2021 · Sixten Körper, Manfred Weiss, et al. · Journal of Clinical Investigation · 95

PDF

Cetuximab plus gemcitabine/oxaliplatin (GEMOXCET) in first-line metastatic pancreatic cancer: a multicentre phase II study

2009 · F Kullmann, S Hollerbach, et al. · British Journal of Cancer · 91

PDF

Cardiac function after orthotopic liver transplantation and the effects of immunosuppression: A prospective randomized trial comparing cyclosporin (Neoral) and tacrolimus

2002 · George Therapondos, Andrew D. Flapan, et al. · Liver Transplantation · 77

PDF

TACE plus sorafenib for the treatment of hepatocellular carcinoma: results of the multicenter, phase II SOCRATES trial

2014 · Andreas Erhardt, Frank Kolligs, et al. · Cancer Chemotherapy and Pharmacology · 70

Indocyanine green clearance reflects reperfusion injury following liver transplantation and is an early predictor of graft function

1999 · John N Plevris, Rajiv Jalan, et al. · Journal of Hepatology · 62

Impact of capsule endoscopy on outcome in mid-intestinal bleeding: a multicentre cohort study in 285 patients

2008 · Jörg G. Albert, Romy Schülbe, et al. · European Journal of Gastroenterology & Hepatology · 55

1184 Extracorporeal Liver Support With the Molecular Adsorbent Recirculating System (mars) in Patients With Acute-on-chronic Liver Failure (aoclf). the Relief Trial

2010 · R. Bañnares, F. Nevens, et al. · Journal of Hepatology · 53

KRAS Mutation in Metastatic Pancreatic Ductal Adenocarcinoma: Results of a Multicenter Phase II Study Evaluating Efficacy of Cetuximab plus Gemcitabine/Oxaliplatin (GEMOXCET) in First-Line Therapy

2011 · F. Kullmann, A. Hartmann, et al. · Oncology · 47

PDF

Propranolol impairs liver regeneration after partial hepatectomy in C57Bl/6-mice by transient attenuation of hepatic lipid accumulation and increased apoptosis

2010 · Jens Walldorf, Christoph Hillebrand, et al. · Scandinavian Journal of Gastroenterology · 41

Intrahepatic proliferation of ‘naive’ and ‘memory’ T cells during liver allograft rejection: primary immune response within the allograft

1998 · Matthias M. Dollinger, Sarah E. M. Howie, et al. · The FASEB Journal · 34

One-year follow-up of the CAPSID randomized trial for high-dose convalescent plasma in severe COVID-19 patients

2022 · Sixten Körper, Beate Grüner, et al. · Journal of Clinical Investigation · 20

PDF

Peripheral eosinophil count both before and after liver transplantation predicts acute cellular rejection

1997 · M M Dollinger, J N Plevris, et al. · Liver Transplantation and Surgery · 18

PDF

Subclinical Ascites Defines an Intermediate Stage Between Compensated and Decompensated Cirrhosis

2012 · A. Zipprich, T. Seufferlein, et al. · Zeitschrift für Gastroenterologie · 15

Thymostimulin versus placebo for palliative treatment of locally advanced or metastasised hepatocellular carcinoma: a phase III clinical trial

2010 · AIO Hepatobiliary Study Group, Matthias M Dollinger, et al. · BMC Cancer · 15

PDF

Coffee consumption protects against progression in liver cirrhosis and increases long‐term survival after liver transplantation

2016 · Kilian Friedrich, Mark Smit, et al. · Journal of Gastroenterology and Hepatology · 13

A randomized, double-blind, multicenter phase II AIO trial with gemcitabine plus sorafenib versus gemcitabine plus placebo in patients with chemotherapy-naive advanced or metastatic biliary tract cancer: First safety and efficacy data.

2011 · M. H. Moehler, C. C. Schimanski, et al. · Journal of Clinical Oncology · 12

Early Detection of Colorectal Cancer: a Multi-Center Pre-Clinical Case Cohort Study for Validation of a Combined DNA Stool Test

2018 · Matthias Dollinger, Susanna Behl, et al. · Clinical Laboratory · 11

Association of serum zinc levels with liver function and survival in patients awaiting liver transplantation

2015 · Kilian Friedrich, Carina Baumann, et al. · Langenbeck s Archives of Surgery · 10

Efficacy, safety, tolerability, and PK of the HDAC inhibitor resminostat in sorafenib-refractory hepatocellular carcinoma (HCC): Phase II SHELTER study.

2012 · Michael Bitzer, Marius Horger, et al. · Journal of Clinical Oncology · 9

Works count: 47

Citation count: 2,318

H-index: 18

I10-index: 24